UBS Group »

Cue Biopharma shares owned by UBS Group

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by UBS Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $843k 27k 31.56

More positions owned by UBS Group

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for UBS Group

Top funds holding Cue Biopharma

Bleichroeder
Driehaus Capital Management
Vanguard Capital Management
Ikarian Capital
Polygon Management
Stempoint Capital
BlackRock
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Diadema Partners
Geode Capital Management
Belvedere Trading
Boothbay Fund Management
UBS Group

View all funds holding Cue Biopharma